Cargando…

A Personalized and Learning Approach for Identifying Drugs with Adverse Events

PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study propose...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sug Kyun, Hur, Ho, Cheon, Eun Kyung, Oh, Ock Hee, Lee, Jeong Seon, Ko, Woo Jin, Kim, Beom Seok, Kwon, YoungOk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653490/
https://www.ncbi.nlm.nih.gov/pubmed/29047249
http://dx.doi.org/10.3349/ymj.2017.58.6.1229
_version_ 1783273228828934144
author Shin, Sug Kyun
Hur, Ho
Cheon, Eun Kyung
Oh, Ock Hee
Lee, Jeong Seon
Ko, Woo Jin
Kim, Beom Seok
Kwon, YoungOk
author_facet Shin, Sug Kyun
Hur, Ho
Cheon, Eun Kyung
Oh, Ock Hee
Lee, Jeong Seon
Ko, Woo Jin
Kim, Beom Seok
Kwon, YoungOk
author_sort Shin, Sug Kyun
collection PubMed
description PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study proposes a novel approach that can improve clinical decision making with recommendations on ADE causative drugs based on patient information, drug information, and previous ADE cases. MATERIALS AND METHODS: We introduce a personalized and learning approach for detecting drugs with a specific adverse event, where recommendations tailored to each patient are generated using data mining techniques. Recommendations could be improved by learning the associations of patients and ADEs as more ADE cases are accumulated through iterations. After consulting the system-generated recommendations, a physician can alter prescriptions accordingly and report feedback, enabling the system to evolve with actual causal relationships. RESULTS: A prototype system is developed using ADE cases reported over 1.5 years and recommendations obtained from decision tree analysis are validated by physicians. Two representative cases demonstrate that the personalized recommendations could contribute to more prompt and accurate responses to ADEs. CONCLUSION: The current system where the information of individual drugs exists but is not organized in such a way that facilitates the extraction of relevant information together can be complemented with the proposed approach to enhance the treatment of patients with ADEs. Our illustrative results show the promise of the proposed system and further studies are expected to validate its performance with quantitative measures.
format Online
Article
Text
id pubmed-5653490
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-56534902017-11-01 A Personalized and Learning Approach for Identifying Drugs with Adverse Events Shin, Sug Kyun Hur, Ho Cheon, Eun Kyung Oh, Ock Hee Lee, Jeong Seon Ko, Woo Jin Kim, Beom Seok Kwon, YoungOk Yonsei Med J Original Article PURPOSE: Adverse drug events (ADEs) are associated with high health and financial costs and have increased as more elderly patients treated with multiple medications emerge in an aging society. It has thus become challenging for physicians to identify drugs causing adverse events. This study proposes a novel approach that can improve clinical decision making with recommendations on ADE causative drugs based on patient information, drug information, and previous ADE cases. MATERIALS AND METHODS: We introduce a personalized and learning approach for detecting drugs with a specific adverse event, where recommendations tailored to each patient are generated using data mining techniques. Recommendations could be improved by learning the associations of patients and ADEs as more ADE cases are accumulated through iterations. After consulting the system-generated recommendations, a physician can alter prescriptions accordingly and report feedback, enabling the system to evolve with actual causal relationships. RESULTS: A prototype system is developed using ADE cases reported over 1.5 years and recommendations obtained from decision tree analysis are validated by physicians. Two representative cases demonstrate that the personalized recommendations could contribute to more prompt and accurate responses to ADEs. CONCLUSION: The current system where the information of individual drugs exists but is not organized in such a way that facilitates the extraction of relevant information together can be complemented with the proposed approach to enhance the treatment of patients with ADEs. Our illustrative results show the promise of the proposed system and further studies are expected to validate its performance with quantitative measures. Yonsei University College of Medicine 2017-11-01 2017-09-28 /pmc/articles/PMC5653490/ /pubmed/29047249 http://dx.doi.org/10.3349/ymj.2017.58.6.1229 Text en © Copyright: Yonsei University College of Medicine 2017 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Shin, Sug Kyun
Hur, Ho
Cheon, Eun Kyung
Oh, Ock Hee
Lee, Jeong Seon
Ko, Woo Jin
Kim, Beom Seok
Kwon, YoungOk
A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title_full A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title_fullStr A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title_full_unstemmed A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title_short A Personalized and Learning Approach for Identifying Drugs with Adverse Events
title_sort personalized and learning approach for identifying drugs with adverse events
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653490/
https://www.ncbi.nlm.nih.gov/pubmed/29047249
http://dx.doi.org/10.3349/ymj.2017.58.6.1229
work_keys_str_mv AT shinsugkyun apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT hurho apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT cheoneunkyung apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT ohockhee apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT leejeongseon apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kowoojin apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kimbeomseok apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kwonyoungok apersonalizedandlearningapproachforidentifyingdrugswithadverseevents
AT shinsugkyun personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT hurho personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT cheoneunkyung personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT ohockhee personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT leejeongseon personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kowoojin personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kimbeomseok personalizedandlearningapproachforidentifyingdrugswithadverseevents
AT kwonyoungok personalizedandlearningapproachforidentifyingdrugswithadverseevents